Apollomics, Inc. (NASDAQ:APLMW) Short Interest Up 2,600.0% in January

Apollomics, Inc. (NASDAQ:APLMW) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 18,900 shares, an increase of 2,600.0% from the December 31st total of 700 shares. Based on an average daily volume of 82,200 shares, the days-to-cover ratio is presently 0.2 days.

Apollomics Stock Performance

Shares of APLMW stock traded down $0.00 on Friday, reaching $0.01. The stock had a trading volume of 22,000 shares, compared to its average volume of 19,479. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.04. The company has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.01.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.